Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [334]
News [1483]
Articles [66]
Editorials [3]
Conferences [72]
elearning [11]
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse...
Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction ( Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA )
29 May 2015
Promising results for nivolumab in advanced liver cancer
Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive...
Promising results for nivolumab in advanced liver cancer ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )
29 May 2015
Nivolumab shows highly promising activity in advanced liver cancer in early...
Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive...
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )
29 May 2015
Real-world targeted treatment based on whole genome sequencing difficult in...
Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst...
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer ( Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia )
1 May 2015
PARP inhibitor combo shows early promise for patients with and without BRCA...
Dr Timothy Yap - Royal Marsden Hospital, London, UK
PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )
1 May 2015
Incidences of liver cancer rising in the USA
Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA
Incidences of liver cancer rising in the USA ( Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA )
30 Apr 2015
New approaches and new partnership models for biomarker based clinical research
Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015
Aims and successes of the 2nd EurocanPlatform project translational research...
Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
Epigenome deregulation in cancer
Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon...
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015
Immunotherapy of cancer: recent progress and future challenges
Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015
2nd EurocanPlatform translational research course is good for networking
Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation